United States · FDA National Drug Code directory
HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8813_93f6a018-8b3d-4f40-be25-902daec19aea
- Product NDC
- 68788-8813
- Form
- TABLET
- Composition / generic term
- HYDROCHLOROTHIAZIDE
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250121
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET in 1 BOTTLE, PLASTIC (68788-8813-1) · 68788-8813-1
- 30 TABLET in 1 BOTTLE, PLASTIC (68788-8813-3) · 68788-8813-3
- 60 TABLET in 1 BOTTLE, PLASTIC (68788-8813-6) · 68788-8813-6
- 100 TABLET in 1 BOTTLE, PLASTIC (68788-8813-8) · 68788-8813-8
- 90 TABLET in 1 BOTTLE, PLASTIC (68788-8813-9) · 68788-8813-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →